IO Biotech, Inc. (IOBTQ)
OTCMKTS · Delayed Price · Currency is USD
0.0051
+0.0011 (27.50%)
At close: Jun 26, 2026
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $366.94 thousand as of June 29, 2026. Its market cap has decreased by -99.63% in one year.
Market Cap
366.94K
Enterprise Value
-12.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since November 8, 2021, IO Biotech's market cap has decreased from 364.82M to 366.94K, a decrease of -99.90%. That is a compound annual growth rate of -77.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 366.94K | -99.16% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -49.45% |
| Nov 8, 2021 | 364.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 515.71K |
| Nextel Medical | 442.78K |
| Lipella Pharmaceuticals | 415.88K |
| Helix BioMedix | 402.23K |
| Actavia Life Sciences | 385.91K |
| Scorpius Holdings | 342.40K |
| Carisma Therapeutics | 338.95K |
| CNBX Pharmaceuticals | 321.15K |